Picture of Diamyd Medical AB logo

DMYD B Diamyd Medical AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Diamyd Medical Partners With JDRF

April 4 (Reuters) - Diamyd Medical AB  DMYDb.ST :
    * DIAMYD MEDICAL PARTNERS WITH JDRF TO ADVANCE THE
DIAGNODE-3
PHASE 3 TRIAL IN TYPE 1 DIABETES
    * CO, JDRF HAVE ENTERED INTO FOUR-YEAR RESEARCH AND
DEVELOPMENT
COLLABORATION
    * COLLABORATION INCLUDES NON-DILUTIVE $5 MILLION AWARD TO
DIAMYD
MEDICAL TO SUPPORT ITS ONGOING PHASE 3 TRIAL WITH PRECISION
MEDICINE ANTIGEN-SPECIFIC IMMUNOTHERAPY DIAMYD
    * GRANT WILL BE FUNDED UNDER JDRF'S INDUSTRY DISCOVERY &
DEVELOPMENT PARTNERSHIPS PROGRAM

Source text for Eikon:  ID:nWkr9ChgXg 
Further company coverage:  DMYDb.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;))

Recent news on Diamyd Medical AB

See all news